All Blog Posts

Research Roundup Neuroscience
Primary antibodies are a powerful tool in basic research. In our new research roundup dedicated to neuroscience, we talk about a mechanism responsible for drug resistance in epileptic patients and a newly discovered and evolutionarily conserved feature of oligodendrocytes.
-
Topics
Celebrating women and raising awareness!
March 8th is international women’s day, celebrated globally. The day is about honoring female achievements and raising awareness for the gender inequalities women face all over the world. Hear from two female managers at Atlas Antibodies about their own experiences, and what advice they would give to young women. -
Employee Spotlight: Marie Utterbäck
Following tradition with our employee spotlight series we now introduce our next person. Meet Marie Utterbäck, one of our product managers who has been on a very interesting journey in our growing company, keep reading to discover it. -
10 ways to look at the human proteome
Antibody-based immunoassays are widely used in exploratory preclinical and pharmaceutical research as tools for discovering new druggable protein targets. Read about the 10 ways to explore and map the human proteome and how it helps researchers and clinicians on their discovery journeys. -
Glioma classification and key molecular pathology
The classification of gliomas is changing profoundly, shifting from a morphology-based guide to a system based on molecular criteria built around their genomic landscape and data from next-generation sequencing. Read more to learn about the key molecular markers that allow the latest classification of gliomas. -
Topics
Research Roundup: cancer research
Our new Research Roundup summarises three cancer research studies that have used polyclonal antibodies from Atlas Antibodies. Today we share insights into a new biomarker for glioma, the metastatic process in colorectal cancer, and the effect of ginseng metabolites on cancer cells proliferation. Learn more! -
Topics
Five questions to better understand T-cell receptors therapy
T-Cell receptors therapy is a growing area of immuno-oncology with recent breakthroughs in clinical settings, thereby demonstrating his therapeutic potential in mitigating tumor development. So what do you know about T-Cell therapy? Read on! Dr. Erika von Euw from T-Cure Bioscience help us to understand it better. -
Research Roundup: cell biology
Do you love cell biology? Here for you are three new research studies showing our antibodies in action. This latest Research Roundup talks about kinesin’s motor domain in microtubules, membranes & trafficking in organelles, and lysosomal protein composition. -
Celebrating 15 years of Atlas Antibodies
This year marks a major milestone for Atlas Antibodies, as it will be 15 years since we started our journey by launching our antibodies webshop. There are many more milestones we want to share with you. Keep reading! -
Research Roundup: stem cell research
Want to see our antibodies in action? Keep reading our latest Research Roundup! The following three studies have successfully utilized Atlas Antibodies products in stem cell research. -
Ion channels as promising biomarkers in cancer
In this blog post, we share bits of evidence about the involvement of voltage-gated ion channels in human cancers, highlighting their promising use as biomarkers. Read on!